Bottom line
FTXH vs DLHIX: the short answer
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and DLHIX (Nomura Healthcare Fund) share a meaningful slice of their top holdings — about 44% by weight.
But DLHIX is far broader, holding 108 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
FTXH is cheaper at 0.6% vs 0.96% — a difference of $36 a year per $10,000 invested.
Over five years, DLHIX returned +7.8% a year vs +6.5% for FTXH.
Updated Nov 19, 2026
FTXH vs DLHIX side by side
| FTXH | DLHIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | First Trust | Voya |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.6% | 0.96% |
| Annual cost per $10k | $60 | $96 |
| 10-yr cost on $10k (prospectus) | — | $1,232 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +24.0% | +22.4% |
| 5-yr return (annualized) | +6.5% | +7.8% |
| 10-yr return (annualized) | — | +10.4% |
| Best quarter | +18.3% | — |
| Worst quarter | −17.4% | — |
| Net assets (fund) | $36.2M | $750.2M |
| Number of holdings | 51 | 108 |
| Portfolio turnover | 35% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of FTXH's top 25 holdings also appear in DLHIX's top 25.
| Holding | FTXH | DLHIX |
|---|---|---|
| Eli Lilly & Company | 7.77% | 4.16% |
| Abbvie Inc | 7.39% | 4.19% |
| Merck & Company Inc | 7.07% | 3.68% |
| Viatris Inc | 3.62% | 2.48% |
| Vertex Pharmaceuticals Inc | 3.41% | 1.66% |
| Amgen Inc | 3.18% | 2.27% |
| Pfizer Inc | 2.97% | 3.84% |
| Gilead Sciences Inc | 2.89% | 3.54% |
| Regeneron Pharmaceuticals Inc | 2.72% | 3.91% |
| Illumina Inc | 1.98% | 2.11% |
| Neurocrine Biosciences Inc | 1.37% | 1.57% |
| Alkermes Plc | 1.35% | 1.82% |
| Halozyme Therapeutics Inc | 1.21% | 2.30% |
Source: SEC Form N-PORT
FTXH top 10
- Eli Lilly & Company — 7.77%
- Abbvie Inc — 7.39%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Biogen Inc — 3.84%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Vertex Pharmaceuticals Inc — 3.41%
- Amgen Inc — 3.18%
DLHIX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
FAQ
What is the difference between FTXH and DLHIX?
Which is cheaper, FTXH or DLHIX?
Should I own both FTXH and DLHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.